search
MEDIPOST
Trends
- 1MEDIPOST Aims to Lead Global Regenerative Medicine▼MEDIPOST: From Korea’s Stem-Cell Pioneer to Global Regenerative Medicine Leader
South Korean stem-cell company MEDIPOST is being profiled as a pioneer in regenerative medicine with ambitions to expand globally. The company, known for developing stem-cell therapies, is positioning itself to move beyond its home market and become a leader in the international regenerative medicine sector.